Top Markets
Coin of the day
Curatis Holding AG Curatis Holding AG

Curatis Holding AG

CURN
อันดับในหุ้น #20206
Curatis Holding AG specializes in the entire lifecycle of pharmaceutical... Curatis Holding AG specializes in the entire lifecycle of pharmaceutical products, including the procurement, advancement, and market release of medications specifically designed for the diagnosis, prevention, and management of rare and specialized medical conditions. The company's extensive product offerings span a broad array of therapeutic areas. These encompass treatments for antiplatelet conditions, metastatic hormone receptor-positive breast cancer, anti-arrhythmic disorders, nasal oil applications, Wilson's disease, antidotes for cyanide poisoning and digoxin toxicity, antihypotensive agents, therapies for bladder pain syndrome/interstitial cystitis, antibiotics, diagnostic tools for ophthalmology, antivirals, ophthalmic/antibiotic combinations, gentamycin collagen sponges, solutions for benign prostatic hyperplasia, immunomodulators, treatments for epilepsy and essential tremor, thyreostatics, therapies for hereditary tyrosinemia type 1, gastroenterological products, additional immunomodulators and thyreostatics, tranquilizers, Helicobacter pylori tests, phosphate binders, specialized nutritional support for dialysis patients, dermatological corticosteroids, antidotes for lead and mercury poisoning, corticostimulants, anti-fog agents, treatments for chorea associated with Huntington's disease, and antiepileptics. In addition to its commercialized portfolio, Curatis is actively engaged in developing new pharmaceutical compounds. Its pipeline includes C-PTBE-01, currently in Phase IIb clinical trials for treating peritumoral brain edema in pediatric patients; C-AM-01, undergoing Phase IIa trials for preventing severe migraine with aura; and C-MOH-01, also in Phase IIa for the treatment and prevention of medication overuse headache. Furthermore, KIN001 is in Phase I clinical trials, targeting rare inflammatory and fibrotic diseases. The company maintains its headquarters in Liestal, Switzerland.
ราคาหุ้น
$25.88
มูลค่าตลาด
$137.20M
การเปลี่ยนแปลง (1 วัน)
2.05%
การเปลี่ยนแปลง (1 ปี)
87.77%
ประเทศ
CH
ซื้อขาย Curatis Holding AG (CURN)

หมวดหมู่

ประวัติราคาหุ้นของ Curatis Holding AG (CURN)
ราคาปิดสูงสุด: $25.29 เมื่อ 2026-08-01

ราคาปิดต่ำสุด: $1.26M เมื่อ 1999-04-01
ประวัติราคาหุ้นของ Curatis Holding AG ตั้งแต่ 1999 ถึง 2026
ผลการดำเนินงานราคาหุ้นรายปี
ปี ประสิทธิภาพ
2026 (TTM) 54.44%
2025 2.02%
2024 524.76%
2023 -95.88%
2022 -83.81%
2021 -17.34%
2020 481.84%
2019 37.23%
2018 -52.65%
2017 -17.39%
2016 -30.62%
2015 -47.06%
2014 -44.60%
2013 13.03%
2012 8.19%
2011 -47.25%
2010 -0.13%
2009 146.64%
2008 -94.83%
2007 -25.49%
2006 -36.45%
2005 -14.30%
2004 -19.20%
2003 8.14%
2002 88.71%
2001 -91.53%
2000 -89.36%
1999 0.00%
ราคาหุ้นของบริษัทที่คล้ายกันหรือคู่แข่ง
บริษัท ราคาหุ้น การเปลี่ยนแปลง 1ปี% ประเทศ
$171.67 -
DE
$164.46 25.10%
DE
$37.82 21.13%
JP
$222.79 32.01%
CH
$21.08 12.12%
IN